Sankyo Pharma Gmbh
Quick facts
Phase 3 pipeline
- Furosemide oral tablets · Cardiovascular
Furosemide inhibits sodium and chloride reabsorption in the loop of Henle, promoting diuresis and reducing fluid overload.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: